Merck & Co. Inc.’s patent infringement lawsuits against generic pharmaceutical manufacturers who filed abbreviated new drug applications for its products.
Generic pharmaceutical manufacturers have submitted ANDA’s to the Food and Drug…
The U.S. Patent and Trademark Office’s reexamination proceedings regarding Merck & Co. Inc.’s Singulair patent are ongoing.
In May 2009, the PTO granted a petition by Article One Partners LLC to…
ValueClick, Inc., continues to pursue a patent infringement complaint against Tacoda, Inc., in the U.S. District Court for the Central District of California.
On July 15, 2008, the Company filed a…
Merck & Co. Inc. continues to evaluate the information provided with an Abbreviated New Drug Application notice to determine what action should be taken.
In January 2009, the Company received notice…
Leap Wireless International Inc. is pursuing the dismissal of Digital Technology Licensing LLC’s patent infringement action in the U.S. District Court for the Southern District of New York.
On April 21,…
Teva Pharmaceuticals Inc. has appealed the decision upholding the validity of Merck & Co. Inc.’s Singulair patent.
On Aug. 19, 2009, the U.S. District Court for the District of New Jersey…
Leap Wireless International Inc. continues to defend the patent infringement complaint filed by DNT LLC.
On May 1, 2009, the Company was sued by DNT in the U.S. District Court for…
Caliper Life Sciences, Inc., and HandyLab, Inc., are discussing a potential licensing arrangement, according to the company’s Form 10-Q filing with the U.S. Securities and Exchange Commission dated Nov. 9,…
A May 2010 Markman hearing for Caliper Life Sciences, Inc.’s patent infringement suit against Shimadzu Corporation has been set by the U.S. District Court for the Eastern District of Texas.
On…
Merck & Co. Inc. and Schering-Plough Corporation continue to pursue a patent infringement lawsuit against generic pharmaceutical manufacturers who filed abbreviated new drug applications for generic ezetimibe (Zetia).
An abbreviated new…